---
layout: post
title: "Raw Data for Safety and Effectiveness Studies; Draft Guidance for Industry; Availability"
date: 2026-02-05 19:09:22 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-09139
original_published: 2024-04-29 00:00:00 +0000
significance: 8.00
---

# Raw Data for Safety and Effectiveness Studies; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 29, 2024 00:00 UTC
**Document Number:** 2024-09139

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry (GFI) #287 entitled "Raw Data for Safety and Effectiveness Studies." This guidance provides information to animal drug sponsors (sponsors) on the use of raw data in the Center for Veterinary Medicine's (CVM's) review of safety and effectiveness studies submitted in support of new animal drug applications. This guidance also describes our recommendations for submitting raw data.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/04/29/2024-09139/raw-data-for-safety-and-effectiveness-studies-draft-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2024-09139

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
